Preimplantation Genetic Diagnosis Market is Booming at a 6.2% CAGR by 2028 | Amgen, Quest Diagnostics, Genentech, Vertex
Preimplantation Genetic Diagnosis Market
SEATTLE, UNITED STATES, UNITED STATES, January 6, 2022 /EINPresswire.com/ -- New Research Study "Preimplantation Genetic Diagnosis Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook" has been added to Coherent Market Insights.
The global preimplantation genetic diagnosis market growth is driven high rate of infertility worldwide. For instance, according to a study in Reproductive Biological Endocrinology, 2015, globally, 48.5 million couples experience infertility. Moreover, an estimated 15% of couples will have trouble conceiving, according to a 2020 report in UCLA Health.
Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/698
The global preimplantation genetic diagnosis market was valued at US$ 50.3 Mn in 2020 and is forecast to reach a value of US$ 81.6 Mn by 2028 at a CAGR of 6.2% between 2021 and 2028.
Major players operating in the global preimplantation genetic diagnosis market are focused on adopting partnership strategies to enhance their market share. For instance, in October 2018, Illumina Inc. signed an agreement with Vitrolife AB for the distribution of Illumina鈥檚 PGT products in EMEA and America.
North America is expected to witness significant growth in the global preimplantation genetic diagnosis market, owing to high rate of infertility in the region. For instance, according to CDC, 2013 and Office on Women鈥檚 Health, 2019, about 9% of men and 10% of women aged 15 to 44 reported infertility problems in the United States.
Major players in the global preimplantation genetic diagnosis market are also focused on adopting expansion strategies to enhance their market share. For instance, in June 2020, Natera, Inc. announced the expansion of its laboratory facility in Austin, Texas, supporting greater test processing capacity.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/698
Major factors that limit growth of the global preimplantation genetic diagnosis market include, scientific, ethical, and policy issues. There are quite a few issues persistent about the safety of the in vitro fertilization in preimplantation genetic diagnosis. The accuracy of these methods is also questioned by a few physicians and researchers.
Key Takeaways
Chromosomal Abnormalities held dominant position in the global preimplantation genetic diagnosis market in 2019, accounting for 20.1% share in terms of value, followed by X-linked diseases and Aneuploidy, respectively.
Major players operating in the global preimplantation genetic diagnosis include, Abbott Laboratories, Amgen, CooperGenomics Inc., CombiMatrix Corporation, F. Hoffman-La-Roche Ltd, Genentech Inc., Genea Ltd., Invitae Corporation, Illumina, Inc., Laboratory Corporation of America Holdings, Natera Inc., Quest Diagnostics, Reproductive Genetics Institute, Inc., Thermo Fisher Scientific, Inc., and Vertex, PerkinElmer, Inc.
Major players operating in the global preimplantation genetic diagnosis market are focused on adopting partnership strategies to enhance their market share. For instance, in July 2020, Thermo Fisher Scientific partnered with First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, for commercialization of next-generation sequencing (NGS)鈥揵ased diagnostics in Russia.
!! 饾悊饾悇饾悡 饾悢饾悘饾悡饾悗 饾煈饾煄% 饾悆饾悎饾悞饾悅饾悗饾悢饾悕饾悡 !!
饾悂饾惍饾惒 饾悡饾悺饾悽饾惉 饾悅饾惃饾惁饾惄饾惀饾悶饾惌饾悶 饾悂饾惍饾惉饾悽饾惂饾悶饾惉饾惉 饾悜饾悶饾惄饾惃饾惈饾惌 @ https://www.coherentmarketinsights.com/insight/buy-now/698
The following are the study objectives for this report:
路 SWOT Analysis focuses on worldwide main manufacturers to define, assess, and analyse market competition. By kind, application, and region, the market is defined, described, and forecasted.
路 Examine the global and main regional market potential and advantage, opportunity and challenge, constraints and risks.
路 Determine whether trends and factors are driving or limiting market growth.
路 By identifying high-growth categories, stakeholders would be able to analyse market potential.
路 Conduct a strategic study of each submarket's growth trends and market contribution.
路 Expansions, agreements, new product launches, and acquisitions in the market are all examples of competitive developments.
路 To create a strategic profile of the main players and analyse their growth plans in depth.
Mr.Shah
Coherent Market Insights
+1 2067016702
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
